RI
KRYS icon

Redwood Investments’s Krystal Biotech KRYS Stock Holding History

Redwood Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$2.03M Sell
11,267
-76
-0.7% -$12.8K 0.76% 42
2024
Q4 		$1.78M Sell
11,343
-53
-0.5% -$9.4K 0.48% 62
2024
Q3 		$2.07M Sell
11,396
-2,533
-18% -$488K 0.62% 49
2024
Q2 		$2.54M Buy
13,929
+5,677
+69% +$953K 0.87% 41
2024
Q1 		$1.45M Buy
+8,252
New +$1.15M 0.42% 87

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Redwood Investments's KRYS Position: Q1 2025 in Review

Redwood Investments reduced its Krystal Biotech (KRYS) stake by 0.67% in Q1 2025, selling an estimated $12.8K and leaving 11,267 shares worth $2.03M. The position accounts for 0.76% of the portfolio, ranked #42.

Redwood Investments first reported a position in KRYS in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.54M in Q2 2024. 299 funds tracked by Wall St. Rank hold KRYS as of Q1 2025.

  • Redwood Investments held 11,267 shares of Krystal Biotech worth $2.03M as of Q1 2025.
  • Redwood Investments sold 76 Krystal Biotech shares in Q1 2025, an estimated $12.8K.
  • Krystal Biotech made up 0.76% of Redwood Investments's portfolio in Q1 2025, its #42 holding.
  • Redwood Investments first reported a position in Krystal Biotech in Q1 2024 and has held it in 5 quarters since.
  • Redwood Investments's Krystal Biotech position peaked at $2.54M in Q2 2024.
  • 299 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2025.

Based on Redwood Investments's 13F filing for Q1 2025, filed 16 May 2025.